BonelliLab

Last month, our team joined the Annual General Recess of the Division of Rheumatology—an inspiring few days of reconnecting, sharing ideas, and reflecting on our progress. Energized to keep advancing science and supporting patients together.

International Day of Women and Girls in Science 11 February

On this International Day of Women and Girls in Science (Wednesday, Feb 11), we celebrate the vital contributions of women to research and innovation and reaffirm our commitment to an inclusive, supportive scientific community.
www.unesco.org/en/days/wome...

Warum KI den Weg zu passgenauen Rheuma-Therapien ebnet Rheumatologie mit Turbo - Michael Bonelli über die Medizin von morgen: Der Professor für experimentelle Rheumatologie treibt an der MedUni Wien ein Ziel voran, das so ambitioniert wie dringend ist: Autoimmunerkrankungen besser verstehen und behandeln. Als Leiter der Clinical and Translational Science Unit will er die Brücke schlagen zwischen Labor und Klinik – und damit den klassischen „Trial-and-Error“-Ansatz in der Rheumatologie ablösen.

I recently joined the Hörgang / Springer Medizin podcast to discuss how AI and cell therapies may help us one day “reset” the immune system in autoimmune disease.
🎧 Listen (in German): www.springermedizin.at/meduni-wien/...

Earlier this week, our SFB-F70 HIT consortium met in Tulbingerkogel for an inspiring retreat! Thanks to Wilfried Ellmeier for hosting. Great discussions, team spirit & collaboration on HDACs in T cell immunity. Proud to be part of this FWF-funded effort 👉 pii.meduniwien.ac.at/forschungspr...

Honored to co-chair a session at #ECP2025 with my colleague Luka Brcic. Great exchanges linking rheumatology, immunology & pathology, key fields in tackling autoimmune & inflammatory diseases. Thanks to the organizers for this inspiring congress! www.esp-pathology.org/event/ecp2025/

Michael Bonelli takes up professorship in experimental rheumatology | MedUni Vienna

Honored to begin my role as Professor of Experimental Rheumatology @meduniwien.ac.at. Leading translational research in precision medicine & cellular immunotherapies, we aim to bridge discovery & care, moving toward curative options for autoimmune diseases. 🔬 tinyurl.com/385e377v

Congrats to Sylvia Knapp and team on their new Science Immunology paper! They show how aged bone marrow drives lung fibrosis by sustaining profibrotic macrophages. Reduced T-reg IL-10 worsens healing, revealing key immune-aging links.

www.science.org/doi/10.1126/...

#Immunology #LungFibrosis

Another great DarkMatter consortium meeting at UMCG in Groningen! Inspiring progress on the microbial, molecular & genetic roots of autoimmune diseases. Big thanks to Eutema, Thomas Vogl, and all participants - looking forward to next year!

Proud moment for our team as Laura Hermann & Teresa Preglej present their latest research on "The Pathogenic Shift: Mechanisms of CD4⁺ T Cell Activation and Differentiation in Rheumatoid Arthritis" at the SFB-F70 Research Program event, which is funded by the @Austrian Science Fund (FWF).

Celebrating #InternationalWomensDay! 🎉 Women shape a better future in every field. March 8th is not just a celebration—it’s a call for action on gender equality.

To mark the day, MedUni Vienna hosted a networking breakfast for female employees to connect, share ideas & inspire each other. #IWD2025

Congrats to our close collaborator & friend Leonhard Heinz on achieving the Interne Karrierevereinbarung (IKV) at Medizinische Universität Wien! 🎉

This well-earned recognition honors his outstanding research, teaching, & dedication to academia.

#AcademicExcellence #MedicalResearch #CareerMilestone

We're excited to have Teresa back on the team after her maternity leave.
Balancing scientific excellence and family life is no small feat, and we deeply appreciate the dedication and talent Teresa brings to our team.
#WomenInScience #RheumatologyResearch

Time-resolved immune dynamics in rheumatoid arthritis under methotrexate therapy Rheumatoid arthritis (RA) is characterized by immune dysregulation, including alterations in peripheral blood mononuclear cell (PBMC) populations and aberrant cytokine signaling. Methotrexate (MTX) is...

Do you want to understand the mechanisms of methotrexate in patients with rheumatoid arthritis?
Check out our latest pre-print, first-authored by Teresa Preglej and Anela Tosevska - www.biorxiv.org/content/10.1...

Thanks to Elisabeth Simader, who is passing the torch to Felix Kartnig to take care of our PBMC database during her upcoming research fellowship ….

Exciting collaborations in action!
We’re part of two Horizon Europe projects: DARK MATTER and SQUEEZE. Within SFB-F70, we study HDACs as targets in autoimmune diseases.
We also collaborate with LBI for Arthritis and Rehabilitation, RTCure, and the PhD Program SHIELD.
Stay tuned for updates!

Yesterday, on the International Day of Women and Girls in Science, we at the Bonelli Lab celebrate the brilliant women shaping the future of research. Science thrives on diversity, and we’re committed to fostering an inclusive, innovative environment.
#WomenInScience #GirlsInSTEM

Our international team values teamwork, ethical research, and a friendly, professional atmosphere.
Based at the General Hospital and affiliated with the Medical University of Vienna, we are part of the Division of Rheumatology, a leading European center for rheumatology research and care.

Welcome to the Bluesky Account of the Bonelli Lab!

Our mission is to understand the pathogenesis of autoimmune diseases and develop new and personalized therapeutic approaches to improve the life of patients with rheumatic diseases.

#Rheumatology

Thank you Matthias!